Company page

Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc. is a public company traded under the ticker AVTX in the American market. The company has a market capitalization of approximately $975.5 million. Avalo focuses on developing innovative therapies for rare diseases, aiming to improve patient outcomes through its research and development efforts.